DGAP-PVR: STADA Arzneimittel AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

        Print
| Source: EQS Group AG
STADA Arzneimittel AG 

26.06.2014 13:05

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------

On June 25, 2014, LSV ASSET MANAGEMENT, CHICAGO, IL, USA has informed us
according to Article 21, Section 1 of the WpHG that via shares its Voting
Rights on STADA Arzneimittel AG, Bad Vilbel, Deutschland, have exceeded the
3% threshold of the Voting Rights on June 23, 2014 and on that day amounted
to 3.02% (this corresponds to 1856353 Voting Rights).
3.02% of Voting Rights (this corresponds to 1856353 Voting Rights) are
attributed to the company in accordance with Article 22, Section 1,
Sentence 1, No. 6 of the WpHG (German Securities Trading Act).
 



26.06.2014 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      STADA Arzneimittel AG
              Stadastraße 2-18
              61118 Bad Vilbel
              Germany
Internet:     www.stada.de
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------